156 related articles for article (PubMed ID: 38239088)
1. Mutations of epigenetic genes and correlation with treatment response in peripheral T-cell lymphoma.
Wei C; Wang W; Li W; Zhang Y; Zhao D; Zhang W; Zhou D
Clin Transl Med; 2024 Jan; 14(1):e1491. PubMed ID: 38239088
[No Abstract] [Full Text] [Related]
2. [Mutations in epigenetic and metabolic regulators in peripheral T-cell lymphoma].
Sakata-Yanagimoto M
Rinsho Ketsueki; 2015 Aug; 56(8):1053-8. PubMed ID: 26345566
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic alterations and advancement of treatment in peripheral T-cell lymphoma.
Zhang P; Zhang M
Clin Epigenetics; 2020 Nov; 12(1):169. PubMed ID: 33160401
[TBL] [Abstract][Full Text] [Related]
4. Genetic Landscape and Classification of Peripheral T Cell Lymphomas.
Sandell RF; Boddicker RL; Feldman AL
Curr Oncol Rep; 2017 Apr; 19(4):28. PubMed ID: 28303495
[TBL] [Abstract][Full Text] [Related]
5. Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas.
Palomero T; Couronné L; Khiabanian H; Kim MY; Ambesi-Impiombato A; Perez-Garcia A; Carpenter Z; Abate F; Allegretta M; Haydu JE; Jiang X; Lossos IS; Nicolas C; Balbin M; Bastard C; Bhagat G; Piris MA; Campo E; Bernard OA; Rabadan R; Ferrando AA
Nat Genet; 2014 Feb; 46(2):166-70. PubMed ID: 24413734
[TBL] [Abstract][Full Text] [Related]
6. Double somatic mosaic mutations in TET2 and DNMT3A--origin of peripheral T cell lymphoma in a case.
Nguyen TB; Sakata-Yanagimoto M; Nakamoto-Matsubara R; Enami T; Ito Y; Kobayashi T; Obara N; Hasegawa Y; Chiba S
Ann Hematol; 2015 Jul; 94(7):1221-3. PubMed ID: 25687841
[No Abstract] [Full Text] [Related]
7. [Dual epigenetic therapy in TET2 gene positive extranodal peripheral T-cell lymphoma with follicular helper T-cell (TFH) phenotype: a case report and literature review].
Lang JY; Lyu R; Song YY; Zou DH; An G
Zhonghua Xue Ye Xue Za Zhi; 2023 Jul; 44(7):590-593. PubMed ID: 37749042
[No Abstract] [Full Text] [Related]
8. Epigenetic Aberrations and Targets in Peripheral T-Cell Lymphoma.
Atallah-Yunes SA; Robertson MJ; Davé UP
Clin Lymphoma Myeloma Leuk; 2022 Sep; 22(9):659-665. PubMed ID: 35577752
[TBL] [Abstract][Full Text] [Related]
9. [Molecular mechanisms of angioimmunoblastic T-cell lymphoma].
Sakata-Yanagimoto M
Rinsho Ketsueki; 2015 Mar; 56(3):246-52. PubMed ID: 25876776
[TBL] [Abstract][Full Text] [Related]
10. Loss of 5-hydroxymethylcytosine is a frequent event in peripheral T-cell lymphomas.
Lemonnier F; Poullot E; Dupuy A; Couronné L; Martin N; Scourzic L; Fataccioli V; Bruneau J; Cairns RA; Mak TW; Bernard OA; de Leval L; Gaulard P
Haematologica; 2018 Mar; 103(3):e115-e118. PubMed ID: 29242297
[No Abstract] [Full Text] [Related]
11. Histone modifier gene mutations in peripheral T-cell lymphoma not otherwise specified.
Ji MM; Huang YH; Huang JY; Wang ZF; Fu D; Liu H; Liu F; Leboeuf C; Wang L; Ye J; Lu YM; Janin A; Cheng S; Zhao WL
Haematologica; 2018 Apr; 103(4):679-687. PubMed ID: 29305415
[TBL] [Abstract][Full Text] [Related]
12. Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters.
Lemonnier F; Couronné L; Parrens M; Jaïs JP; Travert M; Lamant L; Tournillac O; Rousset T; Fabiani B; Cairns RA; Mak T; Bastard C; Bernard OA; de Leval L; Gaulard P
Blood; 2012 Aug; 120(7):1466-9. PubMed ID: 22760778
[TBL] [Abstract][Full Text] [Related]
13. BCL6 locus is hypermethylated in angioimmunoblastic T-cell lymphoma.
Nishizawa S; Sakata-Yanagimoto M; Hattori K; Muto H; Nguyen T; Izutsu K; Yoshida K; Ogawa S; Nakamura N; Chiba S
Int J Hematol; 2017 Apr; 105(4):465-469. PubMed ID: 27921272
[TBL] [Abstract][Full Text] [Related]
14. Somatic RHOA mutation in angioimmunoblastic T cell lymphoma.
Sakata-Yanagimoto M; Enami T; Yoshida K; Shiraishi Y; Ishii R; Miyake Y; Muto H; Tsuyama N; Sato-Otsubo A; Okuno Y; Sakata S; Kamada Y; Nakamoto-Matsubara R; Tran NB; Izutsu K; Sato Y; Ohta Y; Furuta J; Shimizu S; Komeno T; Sato Y; Ito T; Noguchi M; Noguchi E; Sanada M; Chiba K; Tanaka H; Suzukawa K; Nanmoku T; Hasegawa Y; Nureki O; Miyano S; Nakamura N; Takeuchi K; Ogawa S; Chiba S
Nat Genet; 2014 Feb; 46(2):171-5. PubMed ID: 24413737
[TBL] [Abstract][Full Text] [Related]
15. Multistep tumorigenesis in peripheral T cell lymphoma.
Sakata-Yanagimoto M
Int J Hematol; 2015 Nov; 102(5):523-7. PubMed ID: 25628103
[TBL] [Abstract][Full Text] [Related]
16. [Gene mutations in malignant lymphoma].
Chiba S
Rinsho Ketsueki; 2016; 57(12):2554-2563. PubMed ID: 28090025
[TBL] [Abstract][Full Text] [Related]
17. Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell-derived lymphomas.
Vallois D; Dobay MP; Morin RD; Lemonnier F; Missiaglia E; Juilland M; Iwaszkiewicz J; Fataccioli V; Bisig B; Roberti A; Grewal J; Bruneau J; Fabiani B; Martin A; Bonnet C; Michielin O; Jais JP; Figeac M; Bernard OA; Delorenzi M; Haioun C; Tournilhac O; Thome M; Gascoyne RD; Gaulard P; de Leval L
Blood; 2016 Sep; 128(11):1490-502. PubMed ID: 27369867
[TBL] [Abstract][Full Text] [Related]
18. A Survey of Somatic Mutations in 41 Genes in a Cohort of T-Cell Lymphomas Identifies Frequent Mutations in Genes Involved in Epigenetic Modification.
Fernandez-Pol S; Ma L; Joshi RP; Arber DA
Appl Immunohistochem Mol Morphol; 2019 Jul; 27(6):416-422. PubMed ID: 29629950
[TBL] [Abstract][Full Text] [Related]
19. The pathological features of angioimmunoblastic T-cell lymphomas with IDH2
Steinhilber J; Mederake M; Bonzheim I; Serinsöz-Linke E; Müller I; Fallier-Becker P; Lemonnier F; Gaulard P; Fend F; Quintanilla-Martinez L
Mod Pathol; 2019 Jul; 32(8):1123-1134. PubMed ID: 30952970
[TBL] [Abstract][Full Text] [Related]
20. Emerging therapeutic targets in myeloproliferative neoplasms and peripheral T-cell leukemia and lymphomas.
Orlova A; Wingelhofer B; Neubauer HA; Maurer B; Berger-Becvar A; Keserű GM; Gunning PT; Valent P; Moriggl R
Expert Opin Ther Targets; 2018 Jan; 22(1):45-57. PubMed ID: 29148847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]